| Doxorubicin | Approved Investigational | ERAP1 | 51752 |
downregulated | Doxorubicin results in decreased expression of ERAP1 mRNA | 5q15 | |
| Doxorubicin | Approved Investigational | ERBB3 | 2065 |
downregulated | Doxorubicin results in decreased expression of ERBB3 mRNA | 12q13.2 | |
| Doxorubicin | Approved Investigational | ESR1 | 2099 |
upregulated | Doxorubicin results in increased expression of ESR1 mRNA | 6q25.1-q25.2 | |
| Doxorubicin | Approved Investigational | ESR2 | 2100 |
downregulated | Doxorubicin results in decreased expression of ESR2 mRNA | 14q23.2-q23.3 | |
| Doxorubicin | Approved Investigational | ESR2 | 2100 |
upregulated | Doxorubicin results in increased expression of ESR2 mRNA | 14q23.2-q23.3 | |
| Doxorubicin | Approved Investigational | FADD | 8772 |
upregulated | Doxorubicin results in increased expression of FADD mRNA | 11q13.3 | |
| Doxorubicin | Approved Investigational | FAM198B | 51313 |
upregulated | Doxorubicin results in increased expression of FAM198B mRNA | 4q32.1 | |
| Doxorubicin | Approved Investigational | FAS | 355 |
downregulated | Doxorubicin results in decreased expression of FAS mRNA | 10q23.31 | |
| Doxorubicin | Approved Investigational | FAS | 355 |
upregulated | Doxorubicin results in increased expression of FAS mRNA | 10q23.31 | |
| Doxorubicin | Approved Investigational | FASLG | 356 |
upregulated | Doxorubicin results in increased expression of FASLG mRNA | 1q24.3 | |
| Doxorubicin | Approved Investigational | FASN | 2194 |
upregulated | Doxorubicin results in increased expression of FASN mRNA | 17q25.3 | |
| Doxorubicin | Approved Investigational | FDXR | 2232 |
upregulated | Doxorubicin results in increased expression of FDXR mRNA | 17q25.1 | |
| Doxorubicin | Approved Investigational | FKBP8 | 23770 |
upregulated | Doxorubicin results in increased expression of FKBP8 mRNA | 19p13.11 | |
| Doxorubicin | Approved Investigational | FOLR1 | 2348 |
downregulated | Doxorubicin results in decreased expression of FOLR1 mRNA | 11q13.4 | |
| Doxorubicin | Approved Investigational | FOS | 2353 |
downregulated | Doxorubicin results in decreased expression of FOS mRNA | 14q24.3 | |
| Doxorubicin | Approved Investigational | FOS | 2353 |
upregulated | Doxorubicin results in increased expression of FOS mRNA | 14q24.3 | |
| Doxorubicin | Approved Investigational | FSHR | 2492 |
downregulated | Doxorubicin results in decreased expression of FSHR mRNA | 2p16.3 | |
| Doxorubicin | Approved Investigational | G6PD | 2539 |
upregulated | Doxorubicin results in increased expression of G6PD mRNA | Xq28 | |
| Doxorubicin | Approved Investigational | GAD1 | 2571 |
upregulated | Doxorubicin results in increased expression of GAD1 mRNA | 2q31.1 | |
| Doxorubicin | Approved Investigational | GADD45A | 1647 |
upregulated | Doxorubicin results in increased expression of GADD45A mRNA | 1p31.3 | |
| Doxorubicin | Approved Investigational | GADD45G | 10912 |
upregulated | Doxorubicin results in increased expression of GADD45G mRNA | 9q22.2 | |
| Doxorubicin | Approved Investigational | GATA1 | 2623 |
upregulated | Doxorubicin analog results in increased expression of GATA1 mRNA | Xp11.23 | |
| Doxorubicin | Approved Investigational | GATA1 | 2623 |
upregulated | Doxorubicin results in increased expression of GATA1 mRNA | Xp11.23 | |
| Doxorubicin | Approved Investigational | GDF15 | 9518 |
downregulated | Doxorubicin results in decreased expression of GDF15 mRNA | 19p13.11 | |
| Doxorubicin | Approved Investigational | GDF15 | 9518 |
upregulated | Doxorubicin results in increased expression of GDF15 mRNA | 19p13.11 | |